Lymphoma Canada is conducting a survey of CLL patients to appeal to Canadian governments to provide funding for idelalisib (Zydelig) in Canada. Idelalisib (Zydelig) has been approved by the FDA and the European Medicines Agency but Canadians are also trying to gain access to this treatment.
We are looking for CLL patients in Canada and internationally with an idelalisib (Zydelig) experience to complete a 10-minute survey to provide us with the patient input required for the submission.
Be part of the process by sharing the survey with CLL patients and/or completing the survey by midnight Pacific Time on Tuesday, April 7, 2015.
Please share this link and help us spread the word. We need as many CLL patients with an idelalisib (Zydelig) experience to take this online survey. lymphoma.ca/news/idelalisib...
Thank you for your support.